A chimeric IgE that mimics IgE from patients allergic to acid-hydrolyzed wheat proteins is a novel tool for in vitro allergenicity assessment of functionalized glutens.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Background: Acid-hydrolyzed wheat proteins (acid-HWPs) have been shown to provoke severe allergic reactions in Europe and Japan that are distinct from classical wheat allergies. Acid-HWPs were shown to contain neo-epitopes induced by the deamidation of gluten proteins. However, products with variable rates of deamidation can be found.
      Objectives: In this work, we studied the effect of the extent of wheat proteins deamidation on its allergenicity. A recombinant chimeric IgE was produced and compared to patients' IgE for its capacity to assess the IgE-mediated triggering potential of acid-HWPs.
      Methods: Sera from acid-HWP allergic patients were analyzed via ELISA and a functional basophil assay for their IgE reactivity to wheat proteins with different deamidation levels. A chimeric mouse/human IgE (chIgE-DG1) specific for the main neo-epitope, QPEEPFPE, involved in allergy to acid-HWPs was characterized with respect to its functionality and its reactivity compared to that of patients' IgE.
      Results: Acid-HWPs with medium (30%) and high (50-60%) deamidation levels displayed a markedly stronger IgE binding and capacity to activate basophils than those of samples with weak (15%) deamidation levels. The monoclonal chIgE-DG1 allowed basophil degranulation in the presence of deamidated wheat proteins. ChIgE-DG1 was found to mimic patients' IgE reactivity and displayed the same ability to rank acid-HWP products in a degranulation assay.
      Conclusion: Increasing the deamidation level of products from 15% to 60% resulted in an approximately 2-fold increase in their antigenicity and a 100-fold increase in their eliciting potential. The chimeric ChIgE-DG1 may be a useful tool to evaluate functionalized glutens for their allergenic potential. By mimicking patient sera reactivity, chIgE-DG1 also provided data on the patients' IgE repertoire and on the functionality of certain repeated epitopes in gluten proteins.
    • References:
      J Sci Food Agric. 2010 Feb;90(3):409-17. (PMID: 20355061)
      PLoS One. 2014 Sep 10;9(9):e107137. (PMID: 25207551)
      J Agric Food Chem. 2016 May 11;64(18):3678-87. (PMID: 27087556)
      J Agric Food Chem. 2013 Jul 3;61(26):6311-20. (PMID: 23746232)
      Allergy. 2005 Jun;60(6):815-21. (PMID: 15876313)
      J Immunol. 1996 Jul 1;157(1):221-30. (PMID: 8683119)
      Allergol Int. 2013 Dec;62(4):435-45. (PMID: 23963475)
      Mol Nutr Food Res. 2012 Feb;56(2):336-44. (PMID: 22147540)
      Int Arch Allergy Immunol. 2013;160(3):259-64. (PMID: 23075478)
      Clin Exp Allergy. 2003 Jul;33(7):962-70. (PMID: 12859454)
      J Immunol Methods. 1983 Dec 16;65(1-2):225-33. (PMID: 6655241)
      Int Arch Allergy Immunol. 2001 Dec;126(4):277-85. (PMID: 11815734)
      Clin Exp Allergy. 2011 Oct;41(10):1478-92. (PMID: 21771117)
      J Agric Food Chem. 2013 Jun 19;61(24):5706-14. (PMID: 23705589)
      Allergy. 2000 Mar;55(3):294-6. (PMID: 10753023)
      J Allergy Clin Immunol. 2003 Apr;111(4):897-9. (PMID: 12704375)
      J Allergy Clin Immunol. 2015 May;135(5):1249-56. (PMID: 25670011)
      J Agric Food Chem. 2015 Jun 10;63(22):5403-9. (PMID: 25980542)
      J Agric Food Chem. 2015 Jul 29;63(29):6546-54. (PMID: 26186140)
      Int Arch Allergy Immunol. 2008;146(4):307-20. (PMID: 18367844)
      J Allergy Clin Immunol. 2008 Aug;122(2):298-304. (PMID: 18572230)
      J Allergy Clin Immunol. 2016 May;137(5):1557-65. (PMID: 26684291)
      Contact Dermatitis. 2016 Jun;74(6):346-52. (PMID: 27027256)
      Allergy. 2012 Nov;67(11):1392-9. (PMID: 22994386)
      Clin Exp Allergy. 2008 Nov;38(11):1712-26. (PMID: 18823308)
      J Immunol. 2000 Oct 1;165(7):3849-59. (PMID: 11034391)
      Toxicol In Vitro. 2016 Jun;33:29-34. (PMID: 26921666)
      J Allergy Clin Immunol. 2017 Sep;140(3):879-881.e7. (PMID: 28633942)
      PLoS One. 2014 Aug 25;9(8):e106025. (PMID: 25153680)
      Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1189-93. (PMID: 11711775)
      Eur Ann Allergy Clin Immunol. 2006 Feb;38(2):59-61. (PMID: 16711538)
      Clin Exp Allergy. 2011 Feb;41(2):270-80. (PMID: 21143538)
      Allergy. 2014 Oct;69(10 ):1316-23. (PMID: 24943225)
      Allergy. 2012 Aug;67(8):1023-32. (PMID: 22737987)
      Contact Dermatitis. 2007 Feb;56(2):119-20. (PMID: 17244090)
      Allergol Int. 2012 Dec;61(4):529-37. (PMID: 23093796)
    • Accession Number:
      0 (Allergens)
      0 (Peptides)
      0 (Protein Hydrolysates)
      37341-29-0 (Immunoglobulin E)
      8002-80-0 (Glutens)
    • Publication Date:
      Date Created: 20171109 Date Completed: 20171127 Latest Revision: 20181113
    • Publication Date:
      20221213
    • Accession Number:
      PMC5678878
    • Accession Number:
      10.1371/journal.pone.0187415
    • Accession Number:
      29117222